<DOC>
	<DOC>NCT01612481</DOC>
	<brief_summary>Cancer surveillance has a significant cost and generate anxiety for the patient. It is important to avoid exams that will not modify health support or whose results wont allow to decide.</brief_summary>
	<brief_title>Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma</brief_title>
	<detailed_description>Cancer surveillance has a significant cost and generate anxiety for the patient. It is important to avoid exams that will not modify health support or whose results wont allow to decide. Our study will help rationalise surveillance of soft tissue sarcoma and standardize medical practices.</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<criteria>soft tissue sarcoma, histologically proven tumor size &gt; 5 cm (SBR grade 2) or whatever size (SBR grade 3) complete excision (R0 or R1) no metastasis (checked by spiral chest CT) social security covered informed signed consent bone, visceral, uterine, retroperitoneal sarcoma GIST other malignant tumor patients over 70, or for whom thoracic surgery is excluded pneumoconiosis or known system disease breast feeding or pregnant woman patient unable to undergo trail medical follow up for geographic, social or psychological reasons</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>soft tissue sarcoma</keyword>
	<keyword>lung metastasis</keyword>
	<keyword>surveillance</keyword>
</DOC>